MEI Pharma Allocates $110.4M to Litecoin in Treasury Shift

MEI Pharma has become the first publicly traded U.S. company to hold Litecoin as a reserve asset, purchasing approximately 929,548 LTC for $110.4 million. The move was announced in July and August 2025 and was executed in collaboration with GSR and Litecoin’s founder, Charlie Lee, who also sits on MEI Pharma’s board. The company described the acquisition as a long-term store of value and a strategic shift in corporate treasury management. MEI Pharma is listed on NASDAQ under the ticker MEIP [2].

The company’s decision to allocate a significant portion of its treasury to Litecoin signals growing institutional interest in altcoins beyond Bitcoin and Ethereum. This shift is seen as a bold step that could encourage more corporate entities to explore similar strategies, particularly as regulatory clarity around digital assets continues to develop. MEI Pharma did not disclose the specific reasons for choosing Litecoin over other cryptocurrencies, but analysts suggest it may reflect confidence in its potential for future regulatory recognition, including the possibility of a Litecoin-based ETF [4].

Analysts such as Bloomberg’s Eric Balchunas have noted that Litecoin has strong prospects for ETF approval. Balchunas highlighted that any cryptocurrency with more than six months of futures trading on Coinbase’s derivatives exchange has an 85%+ chance of receiving regulatory approval, with timing being the only remaining factor. He and fellow analyst James Seyffart added that Litecoin is viewed as a commodity rather than a security, which may offer it additional advantages in the approval process [5].

On prediction platform Polymarket, the odds of a Litecoin ETF being approved by the end of 2025 have increased to 81%. This reflects growing market optimism about Litecoin’s institutional future. The news of MEI Pharma’s purchase has already driven a 6% price increase in Litecoin over the past 24 hours, with the token reaching $123.69 at the time of reporting. Technical analysts such as Rain and Crypto Dias have pointed to bullish patterns, with some predicting that Litecoin could return to or even surpass its all-time high of $410.26 [7].

MEI Pharma’s decision is not just a symbolic gesture but a concrete integration of blockchain assets into corporate finance. The company’s approach underscores a broader trend of diversification in institutional treasuries, where digital assets are increasingly being considered as alternatives to traditional holdings. While the long-term impact of this move remains to be seen, it has already generated optimism among Litecoin supporters and highlighted the growing intersection between corporate finance and blockchain technology [8].

MEI Pharma’s move has sparked broader conversations about the role of cryptocurrencies in corporate treasury strategies. With more firms potentially following suit, the adoption of digital assets is likely to accelerate, particularly as the regulatory landscape continues to evolve. The decision also underscores the increasing legitimacy of Litecoin as a reserve asset, potentially paving the way for broader institutional acceptance in the future.

MEI Pharma’s purchase of $110.4 million in Litecoin marks a significant milestone in the adoption of digital assets by U.S. public companies [2].

Source:

[1] Yahoo - https://finance.yahoo.com/news/mei-pharma-chooses-not-bitcoin-143823425.html

[2] Coinpaper - https://coinpaper.com/10380/mei-pharma-becomes-first-us-public-firm-to-hold-litecoin-as-reserve-asset

[3] AInvest - https://www.ainvest.com/news/ethereum-news-today-mei-pharma-allocates-100m-litecoin-bold-treasury-shift-2508/

[4] The - https://www.theglobeandmail.com/investing/markets/markets-news/Business%20Wire/33884240/mei-pharma-acquires-litecoin-launches-100m-institutional-treasury-strategy-with-charlie-lee-and-gsr-advising/

[5] MEXC - https://www.mexc.com/news/63834

[6] OKX - https://tr.okx.com/en/learn/litecoin-institutional-adoption-etf-impact

[7] CoinCentral - https://coincentral.com/mei-pharma-launches-110-million-litecoin-treasury-strategy/

[8] Investing.com - https://ng.investing.com/news/cryptocurrency-news/mei-pharma-acquires-100-million-in-litecoin-for-treasury-strategy-432SI-2043478